|
|
Conferences & Courses
|
Current Process Chemistry
June 13-14, 2012 | Princeton, NJ
The overarching conference theme will be how process chemists deal with the challenge of ‘fit for purpose’ process R&D.
|
|
ImVacS
August 13-16, 2012 | Cambridge, MA
The Immunotherapeutics & Vaccine Summit - ImVacS, presents three meetings that address today' s breakthroughs and persistent challenges for developing and manufacturing vaccines in an open, collegial environment.
|
|
Vaccine Quality throughout the Life Cycle
August 13-14, 2012 | Cambridge, MA
CHI's Production & Manufacturing of Vaccines conference, August 16-18, 2011, will discuss the field of vaccine and immunotherapeutic manufacturing.
|
|
|
|
Life Science Media Library
|
Harnessing CHO Cells DVD
January 10, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
Transient Protein Production in Mammalian Cells DVD
January 8, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
|
|
|
|
|
Publications, Reports, & Whitepapers
|
Engineering Next-Generation Therapeutic Proteins
By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of protein engineering. This report discusses new developments in therapeutic protein engineering and developments that are likely to occur through 2020.
|
Therapeutic Protein Production: A Changing Landscape
Therapeutic Protein Production: A Changing Landscape, an Insight Pharma Report, examines the implications of and advances in upstream and downstream operations used in the production of therapeutic proteins.
|
|
|
|
|
|
|